Guardant Health Inc (GH)
23.48
-0.10
(-0.45%)
USD |
NASDAQ |
Nov 05, 16:00
24.50
+1.02
(+4.32%)
After-Hours: 19:13
Guardant Health Debt to Equity Ratio: -707.54 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | -707.54 |
March 31, 2024 | 16.70 |
December 31, 2023 | 7.184 |
September 30, 2023 | 4.990 |
June 30, 2023 | 3.890 |
March 31, 2023 | -25.54 |
December 31, 2022 | 18.90 |
September 30, 2022 | 6.817 |
June 30, 2022 | 3.560 |
March 31, 2022 | 2.130 |
December 31, 2021 | 1.759 |
September 30, 2021 | 1.599 |
June 30, 2021 | 1.438 |
March 31, 2021 | 1.338 |
Date | Value |
---|---|
December 31, 2020 | 0.6209 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | |
December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-707.54
Minimum
Jun 2024
18.90
Maximum
Dec 2022
-34.85
Average
1.599
Median
Sep 2021
Debt to Equity Ratio Benchmarks
Exact Sciences Corp | 0.8041 |
Delcath Systems Inc | 1.071 |
Star Equity Holdings Inc | 0.2451 |
CytoSorbents Corp | 0.817 |
Progyny Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.609B |
Total Liabilities (Quarterly) | 1.611B |
Shareholders Equity (Quarterly) | -1.613M |
Current Ratio | 6.400 |
Net Debt Paydown Yield | -0.02% |